NCT00141089View on ClinicalTrials.gov

Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation.

PHASE3CompletedINTERVENTIONAL
Enrollment

1,026

Participants

Timeline

Start Date

March 31, 2004

Study Completion Date

February 28, 2005

Conditions
Chronic Constipation
Interventions
DRUG

Tegaserod

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00141089 - Assessment of Efficacy and Safety of Tegaserod in Male Patients With Chronic Constipation. | Biotech Hunter | Biotech Hunter